Theme Venous thromboembolism 2015
Venous thromboembolism (VTE) is a potentially fatal disorder that occurs without apparent provocation (primary, or idiopathic) or after exposure to risk factors, such as surgery. In general much is known about the causes and consequences of VTE. In spite of that, many questions remain to be answered. Regarding the mechanisms of VTE the role of inflammation and the contribution of platelets and neutrophils to thrombogenesis is largely unknown. In the diagnosis of VTE there is some development in distinguishing old and new thrombi, but this is still challenging and clinically relevant topic. In the management of the patient with VTE, there is a spectrum of anticoagulants becoming available, but which one is the ideal agent for a given patient. What are avoidable side effects? Are "pleiotropic" drugs like statins useful in preventing recurrent VTE or not? How invasive should we become in the therapy for the patient with ileo-femoral thrombosis, or with pulmonary embolism? How safe are these procedures and how do we deal with the "vulnerable" patient with VTE?
These and many other questions not only merit our attention, but demand an active "think tank" of those active in the field of venous thromboembolism. In this first edition of the Maastricht Consensus Conference on Thrombosis we intend together with a distinguished international faculty and in close interaction with the audience, to develop a roadmap for research that needs to be done!
Click here to download the highlights!